Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.42
Bid: 15.40
Ask: 15.54
Change: -0.34 (-2.16%)
Spread: 0.14 (0.909%)
Open: 15.68
High: 15.76
Low: 15.30
Prev. Close: 15.76
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

1 May 2024 07:00

RNS Number : 6973M
EnQuest PLC
01 May 2024
 

FOR IMMEDIATE RELEASE 1 May 2024

 

ENQUEST PLC ("EnQuest" or "the Company")

TRANSACTIONS IN OWN SHARES

EnQuest PLC (the "Company") announces that, on 30 April 2024, it purchased the following number of its ordinary shares of 5 pence each (the "Ordinary Shares") through Merrill Lynch International ("Merrill Lynch"). Such purchase was effected pursuant to the instructions issued by the Company in accordance with the share repurchase arrangements entered into with Merrill Lynch, as announced on 29 April 2024 (the "Programme").

Aggregated information of Ordinary Shares purchased on 30 April 2024 according to each trading venue:

Venue

Weighted average price paid per share (GBp)

Aggregate number of shares purchased

Lowest price paid per share (GBp)

Highest price paid per share (GBp)

London Stock Exchange

16.16

202,545

16.06

16.26

Chi-X

16.15

5,323

16.04

16.26

BATS

16.13

6,962

16.04

16.22

Turquoise

16.06

97

16.06

16.06

Total (all venues)

16.16

214,927

16.04

16.26

 

Since 29 April 2024, the Company has purchased 371,679 Ordinary Shares to be held in Treasury at a cost (including dealing and associated costs) of £60,572.49.

It is intended that the first 25 million Ordinary Shares purchased under the Programme will be held in Treasury for issue in due course to the Company's Employee Benefit Trust. To the extent permitted by law, and after the initial 25 million Ordinary Shares are purchased, all additional Ordinary Shares purchased under the Programme will be cancelled.

Following the above transaction, there will be 371,679 Ordinary Shares in Treasury and 1,915,552,660 Ordinary Shares in issue (excluding Treasury shares). The total voting rights in the Company will accordingly be 1,915,552,660. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

A full breakdown of the individual trades made by Merrill Lynch on behalf of the Company as part of the share repurchase programme is attached to this document.

Attachment:http://www.rns-pdf.londonstockexchange.com/rns/6973M_1-2024-4-30.pdf

 

LEI: 2138008LJU6WFQWOXJ73

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

Enquiries:

 

EnQuest plc +44 (0)20 7925 4900

Chris Sawyer, Company Secretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSBRGDSCGXDGSG
Date   Source Headline
21st Mar 20197:00 amRNSFinal Results
15th Mar 20197:00 amRNSBoard Appointment
12th Mar 20197:11 amRNSKraken 2P Reserves
5th Feb 20197:00 amRNSOperations update
30th Jan 20193:22 pmRNSBoard Committee Membership
28th Jan 201911:31 amRNSChange of Directors' Details
23rd Jan 201910:08 amRNSHolding(s) in Company
18th Jan 20194:09 pmRNSDirector/PDMR Shareholding
17th Dec 201812:22 pmRNSChange of Director's Details
5th Dec 20187:00 amRNSOperations update
3rd Dec 20187:00 amRNSCompletion of Magnus Transaction
26th Nov 201811:56 amRNSDirector/PDMR Shareholding
16th Nov 201812:10 pmRNSHolding(s) in Company
1st Nov 20182:29 pmRNSDirector/PDMR Shareholding
31st Oct 20189:38 amRNSTotal Voting Rights
24th Oct 201812:11 pmRNSDirector/PDMR Shareholding
23rd Oct 20184:47 pmRNSDirector/PDMR Shareholding
22nd Oct 20186:14 pmRNSResults of Rump Placing
22nd Oct 20187:00 amRNSResult of Rights Issue
4th Oct 20187:00 amRNSMagnus and Thistle Options exercised
2nd Oct 20183:12 pmRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAdmission of Nil Paid Rights
1st Oct 20182:55 pmRNSResults of General Meeting
25th Sep 20187:00 amRNSSwedish Issue Price
24th Sep 20181:43 pmRNSDirector/PDMR Shareholding
7th Sep 20187:00 amRNSMagnus Acquisition and Rights Issue
7th Sep 20187:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSKraken FPSO settlement agreement
31st Jul 20182:17 pmRNSNotice to holders of the Company's Retail Notes
7th Jun 201811:24 amRNSReport on Payments to Govts
24th May 20184:39 pmRNSResult of AGM
24th May 20187:00 amRNSOperations Update
27th Apr 20184:37 pmRNSDirector/PDMR Shareholding
24th Apr 20182:27 pmRNSDirector/PDMR Shareholding
19th Apr 20184:00 pmRNSNotice of AGM and Report & Accounts
29th Mar 20188:57 amRNSDirector/PDMR Shareholding
20th Mar 20187:00 amRNSFull Year Results
21st Feb 20183:56 pmRNSAdmission to Trading
19th Feb 20187:00 amRNSOperations Update
16th Feb 20184:51 pmRNSReplacement: Released in Error
15th Feb 20189:07 amRNSPublication of Final Terms
31st Jan 20187:00 amRNSAGREEMENT WITH BP ON THISTLE DECOMMISSIONING
29th Jan 201810:22 amRNSNotice to holders of the Company's Retail Notes
25th Jan 20183:34 pmRNSHolding(s) in Company
10th Jan 20183:59 pmRNSTotal Voting Rights
8th Jan 20187:00 amRNSBoard Appointment
11th Dec 20177:00 amRNSDirectorate Change
1st Dec 20177:00 amRNSCompletion of Acquisition
30th Nov 20177:00 amRNSOperational Update
26th Oct 20177:00 amRNSLiquidity enhanced by over $100 million

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.